WITH the increasing incidence of re-nal cell carcinoma (RCC) in the United States and the increasing proportion of patients with tumors detected at an early stage (1–5), nephron-sparing ap-proaches are becoming more popular. These alternatives to radical nephrec-tomy include partial nephrectomy, wedge resection, and, more recently, in situ thermal ablation. Five-year survival rates after partial nephrectomy are equivalent to those after radical nephrectomy (6–8), sup-porting the rationale of in situ tumor destruction to further reduce morbid
BACKGROUND: To investigate recurrence rates in patients with T1 renal cell carcinoma (RCC) undergone...
Renal cell carcinoma (RCC) accounts for 3% of all cancers in adults. The indications for Radiofreque...
Renal cell carcinoma (RCC) local recurrence after radical nephrectomy is uncommon. When feasible, su...
Background: Repeat partial nephrectomy (PN) for tumors recurring in the ipsilateral kidney is associ...
<div><p>Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults. Nephron spari...
WOS: 000467768700011PubMed ID: 30308573Purpose of review Currently, small renal masses account for t...
The incidence of renal tumours has been increasing over the last decades because of more frequent ab...
Background: The standard treatment of T1 renal cell carcinoma (RCC) is (partial) nephrectomy. For pa...
While the gold-standard for management of localized renal cell carcinoma (RCC) is partial nephrectom...
Renal preservation therapy has been a promising concept for the treatment of localized renal cell ca...
Objective A systematic review of clinical trials on thermal ablation of T1b RCC was conducted to ass...
<p><em>The wide use of current diagnostic techniques, such as ultrasound study, computed tomography,...
Renal cell carcinoma (RCC) accounts for approximately 3% of malignancies and 80-90% of malignant neo...
Thermal ablation has been established as an alternative treatment for renal cell carcinoma (RCC) in ...
To analyse the current evidence of efficacy and safety of nephron-sparing surgery (NSS) that encompa...
BACKGROUND: To investigate recurrence rates in patients with T1 renal cell carcinoma (RCC) undergone...
Renal cell carcinoma (RCC) accounts for 3% of all cancers in adults. The indications for Radiofreque...
Renal cell carcinoma (RCC) local recurrence after radical nephrectomy is uncommon. When feasible, su...
Background: Repeat partial nephrectomy (PN) for tumors recurring in the ipsilateral kidney is associ...
<div><p>Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults. Nephron spari...
WOS: 000467768700011PubMed ID: 30308573Purpose of review Currently, small renal masses account for t...
The incidence of renal tumours has been increasing over the last decades because of more frequent ab...
Background: The standard treatment of T1 renal cell carcinoma (RCC) is (partial) nephrectomy. For pa...
While the gold-standard for management of localized renal cell carcinoma (RCC) is partial nephrectom...
Renal preservation therapy has been a promising concept for the treatment of localized renal cell ca...
Objective A systematic review of clinical trials on thermal ablation of T1b RCC was conducted to ass...
<p><em>The wide use of current diagnostic techniques, such as ultrasound study, computed tomography,...
Renal cell carcinoma (RCC) accounts for approximately 3% of malignancies and 80-90% of malignant neo...
Thermal ablation has been established as an alternative treatment for renal cell carcinoma (RCC) in ...
To analyse the current evidence of efficacy and safety of nephron-sparing surgery (NSS) that encompa...
BACKGROUND: To investigate recurrence rates in patients with T1 renal cell carcinoma (RCC) undergone...
Renal cell carcinoma (RCC) accounts for 3% of all cancers in adults. The indications for Radiofreque...
Renal cell carcinoma (RCC) local recurrence after radical nephrectomy is uncommon. When feasible, su...